Quant Healthcare Fund
Monthly portfolio · 24 months through Aug-2026
compared to Jul-2026 · as on 31 Aug 2026
Holdings
19
Scheme AUM
₹428 cr
New
4
Exited
6
Increased
1
Reduced
2
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| — | Glaxosmithkline Pharmaceuticals Ltd INE159A01016 | N.A. | 1,48,558 | — | 10.58% | +0.65pp | ₹45.31 cr |
| New | Zydus Lifesciences Limited INE010B01027 | N.A. | 3,42,900 | — | 9.30% | — | ₹39.82 cr |
| Increased | Pfizer Ltd INE182A01018 | N.A. | 80,707 | +32,753 | 8.83% | +3.00pp | ₹37.81 cr |
| — | Alivus Life Sciences INE03Q201024 | N.A. | 2,46,298 | — | 8.08% | +0.89pp | ₹34.62 cr |
| Reduced | Concord Biotech Limited INE338H01029 | N.A. | 2,08,326 | -61,613 | 7.03% | -2.62pp | ₹30.13 cr |
| — | SMS Pharmaceuticals Limited INE812G01025 | N.A. | 7,72,728 | — | 6.71% | -0.57pp | ₹28.73 cr |
| — | IPCA Laboratories Ltd INE571A01038 | N.A. | 1,34,835 | — | 6.22% | +0.28pp | ₹26.63 cr |
| Reduced | Zydus Wellness Ltd INE768C01028 | N.A. | 4,55,818 | -1,85,912 | 5.64% | -3.69pp | ₹24.18 cr |
| — | Aurobindo Pharma Limited INE406A01037 | N.A. | 1,29,172 | — | 5.18% | +0.04pp | ₹22.18 cr |
| — | Strides Pharma Science Ltd INE939A01011 | N.A. | 1,02,255 | — | 2.45% | -0.19pp | ₹10.48 cr |
| — | 91 Days Treasury Bill 03-Sep-2026 IN002026X099 | SOV | 3,00,000 | — | 0.70% | -0.05pp | ₹3 cr |
| — | 91 Days Treasury Bill 10-Sep-2026 IN002026X107 | SOV | 3,00,000 | — | 0.70% | -0.05pp | ₹3 cr |
| — | 91 Days Treasury Bill 17-Sep-2026 IN002026X115 | SOV | 3,00,000 | — | 0.70% | -0.05pp | ₹2.99 cr |
| — | 91 Days Treasury Bill 15-Oct-2026 IN002026X156 | SOV | 3,00,000 | — | 0.70% | -0.05pp | ₹2.98 cr |
| — | 91 Days Treasury Bill 22-Oct-2026 IN002026X164 | SOV | 3,00,000 | — | 0.70% | -0.05pp | ₹2.98 cr |
| New | 91 Days Treasury Bill 05-Nov-2026 IN002026X180 | SOV | 3,00,000 | — | 0.69% | — | ₹2.97 cr |
| New | 91 Days Treasury Bill 19-Nov-2026 IN002026X206 | SOV | 3,00,000 | — | 0.69% | — | ₹2.97 cr |
| New | 91 Days Treasury Bill 27-Nov-2026 IN002026X214 | SOV | 3,00,000 | — | 0.69% | — | ₹2.96 cr |
| — | Sumitomo Chemical India Limited INE258G01013 | N.A. | 25,514 | — | 0.31% | -0.02pp | ₹1.32 cr |
| Exited | Aster DM Healthcare Limited INE914M01019 | N.A. | — | -4,46,671 | — | -9.25pp | — |
| Exited | HFCL Limited INE548A01028 | N.A. | — | -16,16,615 | — | -7.89pp | — |
| Exited | 91 Days Treasury Bill 06-Aug-2026 IN002026X057 | SOV | — | -3,00,000 | — | -0.75pp | — |
| Exited | 91 Days Treasury Bill 13-Aug-2026 IN002026X065 | SOV | — | -3,00,000 | — | -0.75pp | — |
| Exited | 91 Days Treasury Bill 20-Aug-2026 IN002026X073 | SOV | — | -3,00,000 | — | -0.75pp | — |
| Exited | 91 Days Treasury Bill 28-Aug-2026 IN002026X081 | SOV | — | -3,00,000 | — | -0.75pp | — |
Cash & other
| Glenmark Pharmaceuticals Ltd 29/09/2026 | 9.83% | ₹42.09 cr |
| Divi's Laboratories Limited 29/09/2026 | 9.46% | ₹40.52 cr |
| Torrent Pharmaceuticals Ltd 29/09/2026 | 7.87% | ₹33.69 cr |
| Aurobindo Pharma Limited 29/09/2026 | 1.50% | ₹6.42 cr |
| TREPS 01-Sep-2026 DEPO 10 | 22.66% | ₹97.04 cr |
| NCA-NET CURRENT ASSETS | -27.21% | ₹-116.53 cr |